EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

IL-2 signalling sustains pathogenic age-associated B cell homeostasis in lupus

Xiaxia Han, Yang Jiang, Shuangshuang Gu, Yiwei Shen, Huihua Ding, Sheng Chen, Qiong Fu, John B Harley, Dai Dai, Nan Shen

Annals of the Rheumatic Diseases · 2026-02 · 85 (2) · 328-338

DOI: 10.1016/j.ard.2025.08.012 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of the Rheumatic Diseases, 2026-02. Verfasst von Xiaxia Han und 9 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Institute of Rheumatology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. Hauptthemen laut MEDLINE: Lupus Erythematosus, Systemic, Interleukin-2, B-Lymphocytes. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Innovative Research Team of High-level Local Universities in Shanghai, National Natural Science Foundation of China, Shanghai Jiao Tong University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: Despite expanding regulatory T (Treg) cells, low-dose interleukin-2 (IL-2) therapy shows variable clinical efficacy in systemic lupus erythematosus (SLE). Here, we investigated whether previously unrecognised effects of IL-2 on age-associated B cells (ABCs) explain this therapeutic heterogeneity. METHODS: Integrated transcriptomic analysis was used to identify the prevalent signalling pathways associated with lupus pathogenic ABCs. The effects of IL-2 on ABCs were examined. TLR7-driven lupus-prone mice were administered to assess the efficacy of IL-2 therapy. IL-2 responsiveness of ABC was further evaluated in patients with SLE through bioinformatic analysis. RESULTS: Transcriptomic and single-cell analyses revealed elevated IL-2 signalling in ABCs, with a more pronounced IL-2 signature in patients with SLE than in healthy controls. IL2RB, a subunit of the IL-2 receptor, was significantly enriched in ABCs and showed increased chromatin accessibility at its promoter. IL-2 promoted ABC survival and differentiation in a stage-dependent manner. Prior IL-2 administration to recipient mice promoted the persistence of adoptively transferred ABCs. In lupus-prone mice, IL-2 administration increased both ABC and Treg populations without ameliorating disease manifestations with ABC's promotion being more dependent on the disease condition. Additionally, ABCs showed elevated expression of IL-2 receptor correlating with ABC frequency in our cohorts, and activation of IL-2 signalling was further observed in B cells and ABCs from patients with SLE. CONCLUSIONS: This study identified ABCs as a novel target of IL-2, expanding the understanding of IL-2's role in SLE beyond the traditional Treg-centric view and offering insights into the variable therapeutic efficacy of IL-2 in this context.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lupus Erythematosus, SystemicInterleukin-2B-LymphocytesAnimalsMiceHumansSignal TransductionHomeostasisFemaleDisease Models, AnimalMaleAdult

Substanzen

Interleukin-2

Autor:innen und Institutionen

  • Shanghai Institute of Rheumatology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Cincinnati Education and Research for Veterans Foundation, Cincinnati, OH, USA; US Department of Veterans Affairs Medical Center, Research Service, Cincinnati, OH, USA.
  • Shanghai Institute of Rheumatology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China; State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Ren Ji Hospital, Sha…

Förderung

  • Innovative Research Team of High-level Local Universities in Shanghai
  • National Natural Science Foundation of China
  • Shanghai Jiao Tong University
  • US Department of Veterans Affairs
  • National Institutes of Health
  • National Institute of Allergy and Infectious Diseases

Zitieren

APA

Han, X., Jiang, Y., Gu, S., Shen, Y., Ding, H., Chen, S., Fu, Q., Harley, J. B., Dai, D., & Shen, N. (2026). IL-2 signalling sustains pathogenic age-associated B cell homeostasis in lupus. Annals of the Rheumatic Diseases, 85(2), 328-338. https://doi.org/10.1016/j.ard.2025.08.012

Vancouver

Han X, Jiang Y, Gu S, Shen Y, Ding H, Chen S, et al. IL-2 signalling sustains pathogenic age-associated B cell homeostasis in lupus. Annals of the Rheumatic Diseases. 2026;85(2):328-338. doi:10.1016/j.ard.2025.08.012

BibTeX
@article{Han2026,
  author = {Han, Xiaxia and Jiang, Yang and Gu, Shuangshuang and Shen, Yiwei and Ding, Huihua and Chen, Sheng and Fu, Qiong and Harley, John B and Dai, Dai and Shen, Nan},
  title = {IL-2 signalling sustains pathogenic age-associated B cell homeostasis in lupus},
  journal = {Annals of the Rheumatic Diseases},
  year = {2026},
  volume = {85},
  number = {2},
  pages = {328--338},
  doi = {10.1016/j.ard.2025.08.012}
}
Kostenlos starten →